Substance Abuse Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: S1BEF74CBE48EN
Market Monitor Global

Abstracts

Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

This report contains market size and forecasts of Substance Abuse Therapeutics in Global, including the following market information:

Global Substance Abuse Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Substance Abuse Therapeutics market was valued at 18360 million in 2021 and is projected to reach US$ 27810 million by 2028, at a CAGR of 6.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Opioid Addiction Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Substance Abuse Therapeutics include Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories and Teva Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Substance Abuse Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Substance Abuse Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Substance Abuse Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Opioid Addiction
• Tobacco/Nicotine Addiction
• Alcohol Dependence

Global Substance Abuse Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Substance Abuse Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital & Clinics
• Residential (non-hospital)

Global Substance Abuse Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Substance Abuse Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Substance Abuse Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Substance Abuse Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Indivior
• Pfizer
• Alkermes
• Novartis
• Mylan
• Cipla
• Glenmark
• Dr. Reddy's Laboratories
• Teva Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Substance Abuse Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Substance Abuse Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SUBSTANCE ABUSE THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Substance Abuse Therapeutics Market Size: 2021 VS 2028
2.2 Global Substance Abuse Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Substance Abuse Therapeutics Players in Global Market
3.2 Top Global Substance Abuse Therapeutics Companies Ranked by Revenue
3.3 Global Substance Abuse Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Substance Abuse Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Substance Abuse Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Substance Abuse Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Substance Abuse Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Substance Abuse Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Substance Abuse Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Opioid Addiction
  4.1.3 Tobacco/Nicotine Addiction
  4.1.4 Alcohol Dependence
4.2 By Type - Global Substance Abuse Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Substance Abuse Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Substance Abuse Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Substance Abuse Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Substance Abuse Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital & Clinics
  5.1.3 Residential (non-hospital)
5.2 By Application - Global Substance Abuse Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Substance Abuse Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Substance Abuse Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Substance Abuse Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Substance Abuse Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Substance Abuse Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Substance Abuse Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Substance Abuse Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Substance Abuse Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Substance Abuse Therapeutics Revenue, 2017-2028
  6.3.2 US Substance Abuse Therapeutics Market Size, 2017-2028
  6.3.3 Canada Substance Abuse Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Substance Abuse Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Substance Abuse Therapeutics Revenue, 2017-2028
  6.4.2 Germany Substance Abuse Therapeutics Market Size, 2017-2028
  6.4.3 France Substance Abuse Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Substance Abuse Therapeutics Market Size, 2017-2028
  6.4.5 Italy Substance Abuse Therapeutics Market Size, 2017-2028
  6.4.6 Russia Substance Abuse Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Substance Abuse Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Substance Abuse Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Substance Abuse Therapeutics Revenue, 2017-2028
  6.5.2 China Substance Abuse Therapeutics Market Size, 2017-2028
  6.5.3 Japan Substance Abuse Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Substance Abuse Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Substance Abuse Therapeutics Market Size, 2017-2028
  6.5.6 India Substance Abuse Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Substance Abuse Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Substance Abuse Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Substance Abuse Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Substance Abuse Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Substance Abuse Therapeutics Market Size, 2017-2028
  6.7.3 Israel Substance Abuse Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Substance Abuse Therapeutics Market Size, 2017-2028
  6.7.5 UAE Substance Abuse Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Indivior
  7.1.1 Indivior Corporate Summary
  7.1.2 Indivior Business Overview
  7.1.3 Indivior Substance Abuse Therapeutics Major Product Offerings
  7.1.4 Indivior Substance Abuse Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Indivior Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Substance Abuse Therapeutics Major Product Offerings
  7.2.4 Pfizer Substance Abuse Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Alkermes
  7.3.1 Alkermes Corporate Summary
  7.3.2 Alkermes Business Overview
  7.3.3 Alkermes Substance Abuse Therapeutics Major Product Offerings
  7.3.4 Alkermes Substance Abuse Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Alkermes Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Substance Abuse Therapeutics Major Product Offerings
  7.4.4 Novartis Substance Abuse Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Mylan
  7.5.1 Mylan Corporate Summary
  7.5.2 Mylan Business Overview
  7.5.3 Mylan Substance Abuse Therapeutics Major Product Offerings
  7.5.4 Mylan Substance Abuse Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Mylan Key News
7.6 Cipla
  7.6.1 Cipla Corporate Summary
  7.6.2 Cipla Business Overview
  7.6.3 Cipla Substance Abuse Therapeutics Major Product Offerings
  7.6.4 Cipla Substance Abuse Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Cipla Key News
7.7 Glenmark
  7.7.1 Glenmark Corporate Summary
  7.7.2 Glenmark Business Overview
  7.7.3 Glenmark Substance Abuse Therapeutics Major Product Offerings
  7.7.4 Glenmark Substance Abuse Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Glenmark Key News
7.8 Dr. Reddy's Laboratories
  7.8.1 Dr. Reddy's Laboratories Corporate Summary
  7.8.2 Dr. Reddy's Laboratories Business Overview
  7.8.3 Dr. Reddy's Laboratories Substance Abuse Therapeutics Major Product Offerings
  7.8.4 Dr. Reddy's Laboratories Substance Abuse Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Dr. Reddy's Laboratories Key News
7.9 Teva Pharmaceutical
  7.9.1 Teva Pharmaceutical Corporate Summary
  7.9.2 Teva Pharmaceutical Business Overview
  7.9.3 Teva Pharmaceutical Substance Abuse Therapeutics Major Product Offerings
  7.9.4 Teva Pharmaceutical Substance Abuse Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Teva Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Substance Abuse Therapeutics Market Opportunities & Trends in Global Market
Table 2. Substance Abuse Therapeutics Market Drivers in Global Market
Table 3. Substance Abuse Therapeutics Market Restraints in Global Market
Table 4. Key Players of Substance Abuse Therapeutics in Global Market
Table 5. Top Substance Abuse Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Substance Abuse Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Substance Abuse Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Substance Abuse Therapeutics Product Type
Table 9. List of Global Tier 1 Substance Abuse Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Substance Abuse Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Substance Abuse Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Substance Abuse Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Substance Abuse Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Substance Abuse Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Substance Abuse Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Substance Abuse Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Substance Abuse Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Substance Abuse Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Substance Abuse Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Substance Abuse Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Substance Abuse Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Substance Abuse Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Substance Abuse Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Substance Abuse Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Indivior Corporate Summary
Table 31. Indivior Substance Abuse Therapeutics Product Offerings
Table 32. Indivior Substance Abuse Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Substance Abuse Therapeutics Product Offerings
Table 35. Pfizer Substance Abuse Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Alkermes Corporate Summary
Table 37. Alkermes Substance Abuse Therapeutics Product Offerings
Table 38. Alkermes Substance Abuse Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Substance Abuse Therapeutics Product Offerings
Table 41. Novartis Substance Abuse Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Mylan Corporate Summary
Table 43. Mylan Substance Abuse Therapeutics Product Offerings
Table 44. Mylan Substance Abuse Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Cipla Corporate Summary
Table 46. Cipla Substance Abuse Therapeutics Product Offerings
Table 47. Cipla Substance Abuse Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Glenmark Corporate Summary
Table 49. Glenmark Substance Abuse Therapeutics Product Offerings
Table 50. Glenmark Substance Abuse Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Dr. Reddy's Laboratories Corporate Summary
Table 52. Dr. Reddy's Laboratories Substance Abuse Therapeutics Product Offerings
Table 53. Dr. Reddy's Laboratories Substance Abuse Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Teva Pharmaceutical Corporate Summary
Table 55. Teva Pharmaceutical Substance Abuse Therapeutics Product Offerings
Table 56. Teva Pharmaceutical Substance Abuse Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Substance Abuse Therapeutics Segment by Type in 2021
Figure 2. Substance Abuse Therapeutics Segment by Application in 2021
Figure 3. Global Substance Abuse Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Substance Abuse Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Substance Abuse Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Substance Abuse Therapeutics Revenue in 2021
Figure 8. By Type - Global Substance Abuse Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Substance Abuse Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Substance Abuse Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Substance Abuse Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Substance Abuse Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Substance Abuse Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Substance Abuse Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Substance Abuse Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Substance Abuse Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Indivior Substance Abuse Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Substance Abuse Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Alkermes Substance Abuse Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Substance Abuse Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Mylan Substance Abuse Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cipla Substance Abuse Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Glenmark Substance Abuse Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Dr. Reddy's Laboratories Substance Abuse Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Pharmaceutical Substance Abuse Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)